ArticleTurkish journal of chemistry2025
Enhancing analytical performance of tyrosinase-based sensors with nanoparticles for detection of isoproterenol.
Article in Turkish journal of chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, electrochemical biosensors utilizing tyrosinase (Tyr) for the detection of the nonselective beta-adrenergic agonist isoproterenol (ISO) are presented. Three different configurations for immobilizing Tyr on a graphite electrode (GE) are compared: (1) GE modified with poly(diallyldimethylammonium chloride) (PDADMAC), PDADMAC/Tyr/GE; (2) PDADMAC combined with iridium nanoparticles (IrNPs) in a stepwise preparation, resulting in PDADMAC/IrNPs/Tyr/GE; and (3) a composite of PDADMAC and IrNPs mixed with Tyr at a 1:1 (v:v), forming PDADMAC/(IrNPs-Tyr)/GE. Surface morphology was characterized using scanning electron microscopy (SEM). Cyclic voltammetry (CV) and amperometry were applied to characterize the biosensor's performance. Within the linear range of 5 μM to 211 μM, the biosensor PDADMAC/Tyr/GE exhibited a limit of detection (LOD) of 1.4 μM and a limit of quantification (LOQ) of 4.1 μM. PDADMAC/IrNPs/Tyr/GE displayed improved sensitivity with an LOD of 0.9 μM and an LOQ of 2.8 μM. The configuration PDADMAC/(IrNPs-Tyr)/GE demonstrated the best performance with an LOD of 0.3 μM and an LOQ of 0.8 μM. The slopes (0.0147 μA/M, 0.0096 μA/M, and 0.0031 μA/M for PDADMAC/(IrNPs-Tyr)/GE, PDADMAC/IrNPs/Tyr/GE, and PDADMAC/Tyr/GE, respectively) of the concentration dependencies for the three sensor modifications (which represent the analytical sensitivity) demonstrate the achieved enhancement of analytical performance by IrNPs. Furthermore, the biosensor's ability to detect ISO in the presence of potential interferences, such as ascorbic acid, uric acid, and paracetamol, was assessed. Additionally, we demonstrated the biosensor's potential to detect ISO in diluted spiked human serum samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.